Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Potent antifungal agent described by Morishita Roussel

Nov. 1, 1996

New antibiotic from Sankyo

Nov. 1, 1996

Cefzil approved for new indication in U.S.

Nov. 1, 1996

Expanded indications for Abelcet

Oct. 25, 1996

Seventeenth approval for Amphocil/Amphotec

Oct. 25, 1996

Key patents issued covering Applied Microbiology's lanthocins

Oct. 25, 1996

Natural antibacterial chitinase inhibitors

Oct. 25, 1996

New cephalosporin derivatives from Roche

Oct. 25, 1996

Albendazole introduced in the U.S. for two parasitic infections

Oct. 18, 1996

Glaxo Wellcome claims antiviral agents with RNA virus specificity

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...